Grufity logo
Grufity logo

Latest Vivo Capital, LLC Stock Portfolio

$1.10Billion | No. of Holdings #47

Vivo Capital, LLC Performance

2026 Q2+7.18%
YTD+26.00%
2025+125.64%

About Vivo Capital, LLC and 13F Hedge Fund Stock Holdings

Vivo Capital, LLC is a hedge fund based in Palo Alto, CA. On 2026-08-14, the fund reported it's updated stock portfolio. In the 13F Holdings report, Vivo Capital, LLC reported an equity portfolio of $1.1 Billions as of 30 Jun, 2026. <br><br> The top stock holdings of Vivo Capital, LLC are TRVI, PRAX, ERAS. The fund has invested 8.7% of it's portfolio in TREVI THERAPEUTICS INC and 8.3% of portfolio in PRAXIS PRECISION MEDICINES. <br><br> The fund managers got completely rid off TERNS PHARMACEUTICALS INC (TERN), VERADERMICS INC and COGENT BIOSCIENCES INC (COGT) stocks. They significantly reduced their stock positions in PASITHEA THERAPEUTICS CORP (KTTA), UNICYCIVE THERAPEUTICS (UNCY) and ERASCA INC (ERAS). Vivo Capital, LLC opened new stock positions in ACHIEVE LIFE SCIENCES INC. (ACHV), EDITAS MEDICINE INC (EDIT) and ODYSSEY THERAPEUTICS INC. The fund showed a lot of confidence in some stocks as they added substantially to TENAX THERAPEUTICS INC (TENX), ARRIVENT BIOPHARMA INC and MOONLAKE IMMUNOTHERAPEUTICS (MLTX).
Vivo Capital, LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2026
$1.10Billion
  as of Aug 14, 2026

Vivo Capital, LLC Annual Return Estimates Vs S&P 500

Our best estimate is that Vivo Capital, LLC made a return of 7.18% in the last quarter. In trailing 12 months, it's portfolio return was 137.64%.
  • Performance
  • S&P 500

New Buys

Ticker$ Bought
achieve life sciences inc.17,964,200
editas medicine inc11,519,000
odyssey therapeutics inc10,758,200
aura biosciences inc8,283,340
avalo therapeutics inc5,082,000
valneva se3,991,530
inmed pharmaceuticals inc1,237,480
New stocks bought by Vivo Capital, LLC

Additions

Ticker% Inc.
tenax therapeutics inc1,100
arrivent biopharma inc89.87
abivax sa - adr73.21
moonlake immunotherapeutics40.00
alto neuroscience inc16.74
aclaris therapeutics, inc.0.42
Additions to existing portfolio by Vivo Capital, LLC

Reductions

Ticker% Reduced
pasithea therapeutics corp-77.83
unicycive therapeutics-69.27
erasca inc-66.03
sab biotherapeutics inc-36.08
tango therapeutics inc-35.97
dbv technologies sa-30.84
praxis precision medicines-20.00
compass therapeutics inc-18.74
Vivo Capital, LLC reduced stake in above stock

Sold off

Ticker$ Sold
terns pharmaceuticals inc-70,350,500
cogent biosciences inc-16,254,300
veradermics inc-18,945,000
soleno therapeutics inc-9,873,550
compass pathway plc-1,106,000
viridian therapeutics inc-3,252,590
Vivo Capital, LLC got rid off the above stocks

Sector Distribution

Vivo Capital, LLC has about 68.9% of it's holdings in Healthcare sector.

  • Healthcare
  • Others
Sector%
Healthcare68.9
Others31.1

Market Cap. Distribution

Vivo Capital, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.

  • MID-CAP
  • UNALLOCATED
  • SMALL-CAP
  • MICRO-CAP
  • NANO-CAP
Category%
MID-CAP33.7
UNALLOCATED31.1
SMALL-CAP23.8
MICRO-CAP9.3
NANO-CAP2

Stocks belong to which Index?

About 36% of the stocks held by Vivo Capital, LLC either belong to S&P 500 or RUSSELL 2000 index.

  • Others
  • RUSSELL 2000
Index%
Others64
RUSSELL 200036
Top 5 Winners (%)%
MNPR
monopar therapeutics inc
69.0 %
TRVI
trevi therapeutics inc
56.3 %
DTIL
precision biosciences inc
42.9 %
ANTX
an2 therapeutics inc
41.5 %
ACRS
aclaris therapeutics, inc.
41.0 %
Top 5 Winners ($)$
TRVI
trevi therapeutics inc
34.2 M
TNGX
tango therapeutics inc
18.3 M
ERAS
erasca inc
17.4 M
arrivent biopharma inc
15.0 M
ACRS
aclaris therapeutics, inc.
10.3 M
Top 5 Losers (%)%
CMPX
compass therapeutics inc
-53.1 %
SNSE
faeth therapeutics inc
-20.7 %
UNCY
unicycive therapeutics
-18.8 %
KTTA
pasithea therapeutics corp
-18.6 %
DBVT
dbv technologies sa
-18.2 %
Top 5 Losers ($)$
CMPX
compass therapeutics inc
-26.8 M
DBVT
dbv technologies sa
-10.1 M
SNSE
faeth therapeutics inc
-4.7 M
ORIC
oric pharmaceuticals inc
-3.4 M
UNCY
unicycive therapeutics
-2.2 M

Vivo Capital, LLC Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Vivo Capital, LLC

Vivo Capital, LLC has 47 stocks in it's portfolio. About 52.4% of the portfolio is in top 10 stocks. CMPX proved to be the most loss making stock for the portfolio. TRVI was the most profitable stock for Vivo Capital, LLC last quarter.

$1.10BTotal Value
53.00Positions
14 Aug, 2026Last Reported
Current holdings of Current Stock Holdings of Vivo Capital, LLC, last reported on 14 Aug, 2026. Select a row with a linked ticker to view its historical trend.
ExpandHoldingsorted ascending% PortfolioShares Held$ Value% Change
CMPS
Compass Pathway Plc

Compass Pathway Plc

CMPS
Vivo Capital, LLC's holding in Compass Pathway Plc over time
0%0.00
$0.00
0%
decreased 100 percentsold off
DBVT
Dbv Technologies Sa

Dbv Technologies Sa

DBVT
Vivo Capital, LLC's holding in Dbv Technologies Sa over time
2.76%1,844,760
$30.25M
2.76%
decreased 30.84 percentreduced
DRUG
Bright Minds Biosciences Inc

Bright Minds Biosciences Inc

DRUG
Vivo Capital, LLC's holding in Bright Minds Biosciences Inc over time
3.57%557,172
$39.11M
3.57%
unchanged 0 percentunchanged